Amicus Therapeutics (FOLD)
(Delayed Data from NSDQ)
$10.31 USD
+0.03 (0.29%)
Updated Jul 23, 2024 04:00 PM ET
After-Market: $10.30 -0.01 (-0.10%) 7:58 PM ET
4-Sell of 5 4
F Value A Growth B Momentum C VGM
Brokerage Reports
0 items in cart
Amicus Therapeutics, Inc. [FOLD]
Reports for Purchase
Showing records 161 - 176 ( 176 total )
Company: Amicus Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
The Week Ahead in Life Sciences - Upcoming Events for the Week of January 29
Provider: WEDBUSH SECURITIES INC.
Analyst: MOUSSATOS L
Company: Amicus Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
The Week Ahead in Life Sciences - Upcoming Events for the Week of January 22
Provider: WEDBUSH SECURITIES INC.
Analyst: MOUSSATOS L
Company: Amicus Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Company: Amicus Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Initial Look at Phase II Co-Administration "013" Study Data is Positive - More Details Early February
Provider: WEDBUSH SECURITIES INC.
Analyst: WADE G
Company: Amicus Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Biotechnology/Biopharmaceuticals/BioDefense: January 2012 Potential Catalysts & Milestones - Monthly Update
Provider: WEDBUSH SECURITIES INC.
Company: Amicus Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
December 2011 Potential Milestones & Key Events - Monthly Update
Provider: WEDBUSH SECURITIES INC.
Company: Amicus Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
November 2011 Potential Milestones & Key Events - Monthly Update
Provider: WEDBUSH SECURITIES INC.
Company: Amicus Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Biotechnology/Biopharmaceuticals/BioDefense: October 2011 Potential Milestones & Key Events - Monthly Update.
Provider: WEDBUSH SECURITIES INC.
Company: Amicus Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
LIFE SCIENCES: The Week Ahead in Life Sciences - Upcoming Events for the Week of September 25
Provider: WEDBUSH SECURITIES INC.
Analyst: MOUSSATOS L
Company: Amicus Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Biotechnology/Biopharmaceuticals/BioDefense: September 2011 Potential Milestones & Key Events - Monthly Update.
Provider: WEDBUSH SECURITIES INC.
Analyst: WADE G
Company: Amicus Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Q2:11 EPS Reported, Some Clinical Timing Adjustments, Remain NEUTRAL
Provider: WEDBUSH SECURITIES INC.
Analyst: WADE G
Company: Amicus Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
The Week Ahead in Life Sciences - Upcoming Events for the Week of August 7
Provider: WEDBUSH SECURITIES INC.
Analyst: MOUSSATOS L
Company: Amicus Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
August 2011 Potential Milestones & Key Events - Monthly Update
Provider: WEDBUSH SECURITIES INC.
Analyst: WADE G
Company: Amicus Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Revisiting Amicus, Upgrading to NEUTRAL from UNDERPERFORM
Provider: WEDBUSH SECURITIES INC.
Analyst: WADE G
Company: Amicus Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
March 2011 Potential Milestones & Key Events - Monthly Updates
Provider: WEDBUSH SECURITIES INC.